Trial Profile
A study to evaluate the risk of hepatocellular carcinoma beyond first five years of treatment with entecavir or tenofovir in Caucasian chronic hepatitis B patients
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 13 Nov 2017
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B
- Focus Adverse reactions
- 24 Oct 2017 Results of 4-year longitudinal cohort study presented at The Liver Meeting 2017: 68th Annual Meeting of the American Association for the Study of Liver Diseases
- 14 Mar 2016 New trial record